Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug therapy: metronidazole.

× No keyword cloud information.

17 in total

1. Mirtazapine therapy for dysgeusia in an elderly patient.

Authors: Kalpana P Padala; Cheryl K Hinners; Prasad R Padala
Journal: Prim Care Companion J Clin Psychiatry Date: 2006

2. In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents.

Authors: S D Sears; J O'Hare
Journal: Antimicrob Agents Chemother Date: 1988-01 Impact factor: 5.191

3. Immunopathology of ulcerative colitis and Crohn's disease, nonsurgical therapeutic considerations.

Authors: F Bläker; K H Schäfer
Journal: Eur J Pediatr Date: 1982-11 Impact factor: 3.183

Review 4. Adverse reactions to drugs and their physico-chemical properties.

Authors: J G Lewis
Journal: Postgrad Med J Date: 1981-11 Impact factor: 2.401

Review 5. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors: R I Henkin
Journal: Drug Saf Date: 1994-11 Impact factor: 5.606

6. Metronidazole in the treatment of non-specific vaginitis (NSV).

Authors: F Jerve; T B Berdal; P Bohman; C C Smith; O K Evjen; H Gjønnaess; M Gaasemyr; L Hausken; K Hesla; E Hoftvedt
Journal: Br J Vener Dis Date: 1984-06

7. Influence of dose and route of administration on disposition of metronidazole and its major metabolites.

Authors: S Loft; M Døssing; H E Poulsen; J Sonne; K L Olesen; K Simonsen; P B Andreasen
Journal: Eur J Clin Pharmacol Date: 1986 Impact factor: 2.953

8. 1H nuclear magnetic resonance study of metronidazole metabolism by perfused rat liver.

Authors: H Allars; M D Coleman; R S Norton
Journal: Eur J Drug Metab Pharmacokinet Date: 1985 Jul-Sep Impact factor: 2.441

9. Disposition and removal of metronidazole in patients undergoing haemodialysis.

Authors: A Somogyi; C Kong; J Sabto; F W Gurr; W J Spicer; A J McLean
Journal: Eur J Clin Pharmacol Date: 1983 Impact factor: 2.953

10. Phase 1 tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go.10213): a new antiprotozoal agent.

Authors: A B Vaidya; D K Ray; N A Mankodi; T Paul; U K Sheth
Journal: Br J Clin Pharmacol Date: 1983-11 Impact factor: 4.335